Medspresso Partners up with Zootly: South Africa’s Leading Cannabis Destination

CAPE TOWN, SA / ACCESSWIRE / February 9, 2021 / WUHAN GENERAL GROUP, INC. (WUHN) (“Wuhan” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update regarding its MedspressoTm brand focused on creating premium African functional beverages:

This past week MedspressoTm set the seal on its alliance with South African retailer: Zootly. The latter will carry the MedspressoTm product range. Zootly is a Cape Town based online, retail and wholesale distributor of only the highest quality cannabis growing and smoking equipment throughout South Africa.

The new collaboration began when Team Medspresso met Zootly owners, Derek Hewlett and Chris Landman and instantly saw eye-to-eye on their business goals. I absolutely love what Derek and Chris are doing with Zootly and their plans for expansion. They’re really passionate guys with amazing energy and are on a great mission. We’re very excited to be working with them,” said Jeff Robinson, CEO of Wuhan General Group.

The excitement was matched by the team at Zootly. “Medspresso has very high-quality and cool products that align beautifully with the brands we sell on our online and offline shops. We completely loved how the Medspresso products tasted and are looking forward to seeing our customers sharing the same belief. Meeting Jeff Robinson and the Medspresso team was enlightening. We look forward to seeing what the future brings! “said Derek Hewlett , founder of Zootly.

About Zootly

Zootly began when Derek and Chris joined forces to start their venture into the budding marijuana industry in 2018. After deciding to go full-steam ahead, they travelled around the world to establish international relationships with the best distributors. Now located on the trendy Kloof Street in Gardens, Cape Town, the Zootly team sells its own bespoke range of products. This includes an amazing range of Zoot products, growing mediums, vapes, CBD products, and so much more. It is your local cannabis aficionado store that delivers from their online shop.

Follow on Instagram:
Follow on Facebook:

About Medspresso

Medspresso is an eco-conscious brand that encompasses a range of high-quality premium CBD-infused functional beverages including two blends of coffee, Rooibos tea and a hot chocolate beverage that all come in Nespresso compatible pods. The brand sources in-season coffee beans from exceptional producers around Africa. Beverages on the Medspresso menu must pass multiple rigorous cupping and tasting sessions in order to qualify against our stringent standards to ensure every shot is perfect. Behind Medspresso is a team of experienced and passionate coffee-lovers, with a drive to showcase, educate and inspire people about specialty coffee. It is a community-minded brand that is dedicated to providing its community with an excellent quality product.

Follow on Instagram:
Follow on Facebook:

About Wuhan General Group, Inc./ M2Bio Sciences, Inc

Wuhan General Group, Inc. (DBA M2bio Sciences), through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™ and Handcrafted Delights™ brands. In addition, our research and clinical trials with psilocybin are aimed at new therapies that will help patients who suffer from alcohol addiction, mental illness and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research and emerging technologies. The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol “WUHN”.

Publicly traded company (OTC Pink:WUHN)

Follow us on Twitter:
Follow us on Facebook:

Forward-Looking Statements:

Safe Harbour Statement – In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company’s future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company’s business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company’s website. The Company disclaims any responsibility to update any forward-looking statements.

SOURCE: Wuhan General Group, Inc./M2Bio Sciences, Inc

View source version on

error: Content is protected !!